BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25123963)

  • 1. Molecular profiling in fresh tissue with high tumor cell content promotes enrichment for aggressive adenocarcinomas in cervix.
    Halle MK; Krakstad C; Engerud H; Bertelsen B; Salvesen HB
    Pathol Res Pract; 2014 Nov; 210(11):774-8. PubMed ID: 25123963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis Phenomena in Squamous Cell Carcinomas and Adenocarcinomas of the Uterine Cervix.
    Eduardo MG; Campaner AB; Silva MA
    Pathol Oncol Res; 2015 Sep; 21(4):887-92. PubMed ID: 25682239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L1 cell adhesion molecule (L1CAM) in stage IB cervical cancer: distinct expression in squamous cell carcinomas and adenocarcinomas.
    Mancusi de Carvalho JP; Salim RC; Carvalho FM; Nogueira Dias Genta ML; Baracat EC; Carvalho JP
    J Clin Pathol; 2020 Nov; 73(11):748-753. PubMed ID: 32366597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma.
    Eifel PJ; Burke TW; Morris M; Smith TL
    Gynecol Oncol; 1995 Oct; 59(1):38-44. PubMed ID: 7557613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Fregnani JH; Soares FA; Novik PR; Lopes A; Latorre MR
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):215-23. PubMed ID: 17125903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.
    Kajiyama H; Shibata K; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Fujiwara S; Kikkawa F
    Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of programmed death-ligand 1 expression in adenocarcinoma and squamous cell carcinoma of the cervix in paraffin blocks of patients with cervical cancer.
    Hosseini MS; Shafizadeh F; Bahremani MH; Farzaneh F; Ashrafganjoei T; Arab M; Talayeh M; Jafari F; Abdshah A
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2057. PubMed ID: 38662366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 in surgically treated and pathologically staged cervical cancer: correlation with local tumor progression, but not with lymphatic spread.
    Horn LC; Fischer U; Hänel C; Kuhn H; Raptis G; Bilek K
    Pathol Res Pract; 2001; 197(9):605-9. PubMed ID: 11569924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients.
    Heidegger H; Dietlmeier S; Ye Y; Kuhn C; Vattai A; Aberl C; Jeschke U; Mahner S; Kost B
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonographic characteristics of squamous cell cancer and adenocarcinoma of the uterine cervix.
    Epstein E; Di Legge A; Måsbäck A; Lindqvist PG; Kannisto P; Testa AC
    Ultrasound Obstet Gynecol; 2010 Oct; 36(4):512-6. PubMed ID: 20336641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment.
    Silva LS; Goncalves LG; Silva F; Domingues G; Maximo V; Ferreira J; Lam EW; Dias S; Felix A; Serpa J
    Tumour Biol; 2016 Apr; 37(4):5385-95. PubMed ID: 26563366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
    Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
    Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of aquaporin-8 and bcl-2 protein in human cervical carcinoma and their correlations].
    Yao JF; Zhou CY; Wei LF; Wang SY; Shi YF
    Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):205-8. PubMed ID: 18788571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expressions of bcl-2 and survivin, and decreased apoptosis in uterine cervical carcinosarcoma compared to cervical squamous cell carcinoma.
    Gan XL; Li JK; Yu TH; Zhang Y; Hu LN
    Arch Gynecol Obstet; 2011 Jul; 284(1):175-81. PubMed ID: 20668868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine cervical carcinomas associated with lobular endocervical glandular hyperplasia.
    Tsuji T; Togami S; Nomoto M; Higashi M; Fukukura Y; Kamio M; Yonezawa S; Douchi T
    Histopathology; 2011 Jul; 59(1):55-62. PubMed ID: 21771026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p16 protein and epidermal growth factor receptor in patients with adenocarcinoma of the uterine cervix: an immunohistochemical analysis.
    Bodner K; Laubichler P; Kimberger O; Czerwenka K; Zeillinger R; Bodner-Adler B
    Arch Gynecol Obstet; 2011 Mar; 283(3):611-6. PubMed ID: 20405295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune checkpoints CTLA-4 and PD-L1 in carcinomas of the uterine cervix.
    Karpathiou G; Chauleur C; Mobarki M; Peoc'h M
    Pathol Res Pract; 2020 Jan; 216(1):152782. PubMed ID: 31862202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.